During the COVID‐19 pandemic where has respiratory syncytial virus gone?

G Di Mattia, R Nenna, E Mancino, V Rizzo… - Pediatric …, 2021 - Wiley Online Library
The diffusion of the SARS‐CoV‐2 virus and the implementation of restrictive measures led to
a drastic reduction of respiratory syncytial virus (RSV) diffusion. Few RSV cases have been …

RSV disease in infants and young children: Can we see a brighter future?

E Baraldi, G Checcucci Lisi, C Costantino… - Human Vaccines & …, 2022 - Taylor & Francis
Respiratory syncytial virus (RSV) is a highly contagious seasonal virus and the leading
cause of Lower Respiratory Tract Infections (LRTI), including pneumonia and bronchiolitis in …

[HTML][HTML] Biological factors that may impair transplacental transfer of RSV antibodies: implications for maternal immunization policy and research priorities for low-and …

JE Atwell, CS Lutz, EG Sparrow, DR Feikin - Vaccine, 2022 - Elsevier
Respiratory syncytial virus (RSV) is the leading viral cause of acute lower respiratory tract
infection (ALRI), including bronchiolitis and pneumonia, in infants and children worldwide …

Transfer of respiratory syncytial virus prefusion F protein antibody in low birthweight infants

AB Kachikis, K Rumfelt, M Pike, M Sosa… - Open Forum …, 2024 - academic.oup.com
Background Respiratory syncytial virus (RSV)–associated lower respiratory tract infection
contributes significantly to morbidity/mortality worldwide in low birthweight (LBW) infants (< …

The Epidemiology of Pathogens in Community‐Acquired Pneumonia Among Children in Southwest China Before, During and After COVID‐19 Non‐pharmaceutical …

R Yang, H Xu, Z Zhang, Q Liu, R Zhao… - Influenza and Other …, 2024 - Wiley Online Library
Objective This study aimed to investigate the pathogen epidemiology of community‐
acquired pneumonia (CAP) among children in Southwest China before, during and after the …

[HTML][HTML] High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in …

S Pasittungkul, I Thongpan, P Vichaiwattana… - International Journal of …, 2022 - Elsevier
Objectives To investigate the seroprevalence of respiratory syncytial virus (RSV) infections
in young children, the correlation between RSV antibody levels in maternal and cord serum …

Antibody-mediated protection against respiratory syncytial virus in children

EL Coindy, C Efstathiou, S Talwar… - European …, 2024 - publications.ersnet.org
Respiratory syncytial virus (RSV) is a major global pathogen, causing lower respiratory tract
disease in at-risk populations including young children. Antibodies form a crucial layer of …

[PDF][PDF] RSV lower respiratory tract illness in infants of low-and middle-income countries.

SL Laudanno, CIS Yanotti, FP Polack - Acta medica academica, 2020 - researchgate.net
This review addresses differences in respiratory syncytial virus (RSV) lower respiratory tract
illness (LRTI) between industrialized and develo** countries and provides observations …

Passive Immunization Strategies to Prevent Severe Respiratory Syncytial Virus Infection Among Newborns and Young Infants

M Suryadevara - Journal of the Pediatric Infectious Diseases …, 2024 - academic.oup.com
Newborns and young infants are at risk for severe respiratory syncytial virus (RSV) lower
respiratory tract infection. Passive immunity is the mainstay of infection prevention in this …

[HTML][HTML] Disease burden of respiratory syncytial virus infection in the pediatric population in Japan

K Nagasawa, N Ishiwada - Journal of Infection and Chemotherapy, 2022 - Elsevier
Introduction Respiratory syncytial virus (RSV) is one of the most common causes of lower
respiratory tract infections in children aged< 5 years and is associated with long-term …